Research from Water Tower Research, Water Tower Research

Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Research from Water Tower Research

Equity Research Firm

Equity Bottom-Up

<ul><li>Near-term debt obligation reduced, strengthening the balance sheet.</li><li>On July 15, 2026, Seneca Partners filed a Schedule 13D confirming that its affiliated V-Co Investors converted $1.1 million of convertible debt into equity as part of a $1.6-million financing, reducing near-term debt obligations and simplifying Vivos’ capital structure while reinforcing support from an existing anchor investor.</li><li>The Streeterville secured note remains outstanding, with up to $4.5 million conditionally convertible into equity under the extended exchange agreement.</li></ul>

Near-term debt obligation reduced, strengthening the balance sheet.On July 15, 2026, Seneca Partners filed a Schedule 13D confirming that its affiliated V-Co Investors converted $1.1 million of convertible debt into equity as part of a $1.6-million financing, reducing near-term debt obligations and simplifying Vivos’ capital structure while reinforcing support from an existing anchor investor.The Streeterville secured note remains outstanding, with up to $4.5 million conditionally convertible into equity under the extended exchange agreement.

VVOS: Balance Sheet Repair Underway as Anchor Investor Steps Up

Vivos Therapeutics

VVOS: Balance Sheet Repair Underway as Anchor Investor Steps Up